ESMO® 2025 Highlights: Presenter Vignette – Atul Batra

Dr. Atul Batra

Atul Batra

MD, DM

Dr. B. R. Ambedkar Institute Rotary Cancer Hospital

LBA15

Low Dose Pembrolizumab in Addition to Neoadjuvant Anthracycline and Taxane in Triple Negative Breast Cancer: A Randomized Controlled Trial